Angion Biomedica (ANGN) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free ANGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1, 2023 | finance.yahoo.comAngion Biomedia Corp. Announces 1-for-10 Reverse Stock SplitMay 2, 2023 | marketwatch.com8-K: Angion Biomedica Corp.April 27, 2023 | finance.yahoo.comCompanies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite RiskyApril 11, 2023 | markets.businessinsider.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVAApril 6, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIGMarch 4, 2023 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, DCT, ANGNFebruary 24, 2023 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, OSH, IAAJanuary 22, 2023 | benzinga.comMoore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law FirmJanuary 18, 2023 | benzinga.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Angion Biomedica Corp. - ANGNJanuary 17, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Angion Biomedica Corp. MergerJanuary 17, 2023 | marketwatch.comAngion Biomedica Shares Tumble Premarket on Elicio Tie-Up >ANGNJanuary 17, 2023 | technews.tmcnet.comANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to ShareholdersDecember 27, 2022 | finance.yahoo.comBullish insiders bet US$857k on Angion Biomedica Corp. (NASDAQ:ANGN)December 22, 2022 | finanznachrichten.deAngion Biomedica Corp.: Angion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsDecember 22, 2022 | finance.yahoo.comAngion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsNovember 29, 2022 | nasdaq.comNabriva (NBRV) Posts Positive Data From Cystic Fibrosis StudyNovember 29, 2022 | nasdaq.comAxsome (AXSM) Gains as Alzheimer's Agitation Study Meets GoalNovember 24, 2022 | msn.comReasons to Add Immunovant (IMVT) Stock to Your Portfolio NowNovember 17, 2022 | nasdaq.comImmunovant (IMVT) Rises More Than 150% in 3 Months: Here's HowNovember 10, 2022 | finance.yahoo.comJazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive SalesNovember 4, 2022 | finance.yahoo.comKaruna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 LossNovember 1, 2022 | finance.yahoo.comLilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 ViewOctober 13, 2022 | finance.yahoo.comIs Angion Biomedica (NASDAQ:ANGN) In A Good Position To Deliver On Growth Plans?September 24, 2022 | finance.yahoo.comAngion Biomedica Corp. (ANGN)September 12, 2022 | msn.comAngion Biomedica's Return On Capital Employed OverviewSeptember 9, 2022 | morningstar.comAngion Biomedica Corp Ordinary SharesAugust 17, 2022 | benzinga.comRecap: Angion Biomedica Q2 EarningsAugust 15, 2022 | finance.yahoo.comAngion Provides Corporate Update and Reports Second Quarter 2022 Financial ResultsJuly 25, 2022 | finance.yahoo.comAngion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder ValueJuly 25, 2022 | marketbeat.comTrading was temporarily halted for "ANGN" at 04:07 PM with a stated reason of "News pending."July 18, 2022 | finance.yahoo.comHC Wainwright Downgrades Angion BiomedicaJuly 1, 2022 | morningstar.comAngion Biomedica Corp Ordinary Shares - Stock Quote ANGNJuly 1, 2022 | marketwatch.comAngion Biomedica Shares Plumb New Depths After Study Setback >ANGNJune 30, 2022 | finance.yahoo.comAngion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read WhyJune 29, 2022 | finance.yahoo.comAngion Biomedica shares dive after kidney-disease drug trial discontinuedJune 29, 2022 | finance.yahoo.comAngion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney DiseaseJune 29, 2022 | seekingalpha.comAngion to discontinue phase 2 trial of ANG-3070 in patients with kidney diseaseJune 29, 2022 | marketbeat.comTrading was temporarily halted for "ANGN" at 04:06 PM with a stated reason of "News pending."May 28, 2022 | finance.yahoo.comJay Venkatesan Is The President of Angion Biomedica Corp. (NASDAQ:ANGN) And They Just Picked Up 5.7% More SharesMay 16, 2022 | finance.yahoo.comAngion Provides Corporate Update and Reports First Quarter 2022 Financial ResultsMay 16, 2022 | finance.yahoo.comAngion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary FibrosisMay 11, 2022 | finance.yahoo.com5 Biotech Stocks Set to Outpace Q1 Earnings EstimatesMay 6, 2022 | finance.yahoo.comHere's Why We're Watching Angion Biomedica's (NASDAQ:ANGN) Cash Burn SituationApril 14, 2022 | finance.yahoo.comAngion Announces Participation in Upcoming Investment ConferenceApril 1, 2022 | seekingalpha.comAngion Biomedica GAAP EPS of -$1.93, revenue of $28.31MMarch 30, 2022 | finance.yahoo.comAngion Provides Corporate Update and Reports Full Year 2021 Financial ResultsMarch 15, 2022 | msn.comPrecision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue EstimatesMarch 10, 2022 | nasdaq.comEvogene (EVGN) Reports Q4 Loss, Tops Revenue EstimatesMarch 6, 2022 | finance.yahoo.comShareholders in Angion Biomedica (NASDAQ:ANGN) are in the red if they invested a year agoFebruary 28, 2022 | finance.yahoo.comAngion Announces Participation in Upcoming Investment Conferences Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here ANGN Media Mentions By Week ANGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGN News Sentiment▼0.000.79▲Average Medical News Sentiment ANGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGN Articles This Week▼00▲ANGN Articles Average Week Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SAB Biotherapeutics News Today LianBio News Today Acasti Pharma News Today Lipocine News Today ZIVO Bioscience News Today HCW Biologics News Today Alaunos Therapeutics News Today Brainstorm Cell Therapeutics News Today IN8bio News Today PHAXIAM Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGN) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Angion Biomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
